We develop innovative biopharmaceuticals based on stem cells.
Bioceltix has raised €2.5M across 2 funding rounds from 1 investor, most recently a round in Jan 2024. Based in Warsaw, Poland; founded 2016; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2024-01-10 | Other | €2.5M | European Funds for a Modern Economy (FENG) | View deal → |
| 2019-10-01 | Other | €0 | — | View deal → |
